Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Oncotarget|November 20, 2020
Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cellsNoymi Yam, Jason Levin, Zhengzheng Bao, et al.NAR Genomics and Bioinformatics|February 12, 2021
Authentication, characterization and contamination detection of cell lines, xenografts and organoids by barcode deep NGS sequencingXiaobo Chen, Wubin Qian, Zhenzhen Song, et al.Cancer Research|June 22, 2016
Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell LinesSheng Guo, Wubin Qian, Jie Cai, et al.Oncotarget|October 30, 2015
A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutationsDawei Chen, Xuesong Huang, Jie Cai, et al.JCI Insight|June 30, 2026
The molecular similarity landscape of preclinical cancer models to patient tumorsZixuan Xie, Jia Xue, Binchen Mao, et al.Cancer Research Communications|March 6, 2023
Tumor Purity in Preclinical Mouse Tumor ModelsWubin Qian, Xiaobo Chen, Yanghui Sheng, et al.Cancer Research Communications|May 12, 2025
Impact of Subcutaneous Versus Orthotopic Implantations on Patient-Derived Xenograft Transcriptomic ProfilesYanghui Sheng, Zixuan Xie, Jingjing Wang, et al.Oncotarget|May 27, 2017
Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft modelsBaoan Hong, Yong Yang, Sheng Guo, et al.Cancer Cell International|September 28, 2020
Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese populationQiang Zhao, Jia Xue, Baoan Hong, et al.Plos One|December 31, 2008
A recalibrated molecular clock and independent origins for the cholera pandemic clonesLu Feng, Peter R Reeves, Ruiting Lan, et al.Pageof 3